NCT05574374

Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects

A Randomized, Open-label, Three-sequence, Three-period, Multiple Dosing Crossover, Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacodynamics of DWC202202 in Combination With DWP14012 in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 36 (actual)
• Sponsor: Daewoong Pharmaceutical Co. LTD. · Industry
• Sex: All
• Age: 19 Years – 50 Years
• Healthy volunteers: Accepted

Summary

A randomized, open-label, three-sequence, three-period, multiple dosing crossover, phase 1 clinical trial to evaluate the effect of DWP14012 on the pharmacodynamics of DWC202202 in combination with DWP14012 in healthy subjects

Conditions

• Drug Drug Interaction

Interventions

Type	Name	Description
DRUG	DWP14012	Potassium-competitive acid blocker
DRUG	DWC202202	Clopidogrel Bisulfate
DRUG	DWC202203	Proton pump inhibitor

Timeline

• Start date: 2022-09-21
• Primary completion: 2023-03-06
• Completion: 2023-03-06
• First posted: 2022-10-10
• Last updated: 2023-04-04

Locations

1 site across 1 country: South Korea